Researchers have generated new insights about postmenopausal women into the ways in which physical activity affects how much estrogen is broken down and secreted in the urine.
These findings enhance understanding of the potential biological mechanisms linking increased physical activity and decreased risk for breast cancer in postmenopausal women, according to the scientist who presented the data at the AACR Annual Meeting 2013, held in Washington, D.C., April 6-10.
Exemestane Can Prevent 65 Percent of Tumors in Post-menopausal Women
The aromatase inhibitor Exemestane can prevent the breast cancer risk by 65 percent in moderate- to high-risk postmenopausal women.
Advertisement
Previous studies have suggested that increased physical activity may reduce the risk for breast cancer among postmenopausal women, and that this might be a result of physical activity lowering endogenous estrogen levels, according to Cher Dallal, Ph.D., a National Cancer Institute (NCI) cancer prevention fellow. However, few studies have evaluated the influence of physical activity on the breakdown of estrogens in postmenopausal women. This breakdown process, called estrogen metabolism, results in a variety of molecules known as metabolites.
"This is the first study to consider the relationship between accelerometer-measured activity and a panel of estrogen metabolites measured in urine," said Dallal. "We hoped by using direct measures to examine this relationship that we could improve our knowledge of how these factors may influence cancer risk among postmenopausal women."
![Weight Gain During Menopause Promotes Breast Tumor Development]( "Weight Gain During Menopause Promotes Breast Tumor Development")
Taking measures to prevent weight gain during perimenopause may help obese women to eliminate their risk of postmenopausal breast cancer risk.
Dallal and colleagues studied 540 healthy, postmenopausal women who were enrolled in the NCI Polish Breast Cancer Study, conducted from 2000 to 2003. None of the women were taking menopausal hormone therapy. The investigators measured physical activity by accelerometer, which is a small device that women wore on their waists during waking hours for seven days. According to Dallal, accelerometers provide objective readings of physical activity compared with participants self-reports, which have been the predominant measure in previous studies.
Women also provided a 12-hour urine sample. The researchers tested the samples for estradiol and estrone, two "parent" estrogens, plus 13 different estrogen metabolites using a new assay developed by the NCI. According to Dallal, this novel assay can detect multiple urinary estrogens, compared with those used in previous studies that only measured one or two metabolites individually.
The researchers found that increased physical activity was associated with lower levels of parent estrogens. In addition, higher levels of physical activity were associated with lower levels of four specific estrogen metabolites. Dallal cautions, however, that further research on estrogen metabolism will be needed to understand how these metabolites play a role in mediating breast cancer risk.
"By using these new tools to study the relationship between activity and estrogen metabolism, we hope to get closer to uncovering the combination of parent estrogens, metabolites and metabolism pathways that are related to a lower-risk profile of breast cancer," said Dallal.
Source: Newswise
Weight Gain During Menopause Promotes Breast Tumor Development
Taking measures to prevent weight gain during perimenopause may help obese women to eliminate their risk of postmenopausal breast cancer risk.
Advertisement
Dallal and colleagues studied 540 healthy, postmenopausal women who were enrolled in the NCI Polish Breast Cancer Study, conducted from 2000 to 2003. None of the women were taking menopausal hormone therapy. The investigators measured physical activity by accelerometer, which is a small device that women wore on their waists during waking hours for seven days. According to Dallal, accelerometers provide objective readings of physical activity compared with participants self-reports, which have been the predominant measure in previous studies.
Women also provided a 12-hour urine sample. The researchers tested the samples for estradiol and estrone, two "parent" estrogens, plus 13 different estrogen metabolites using a new assay developed by the NCI. According to Dallal, this novel assay can detect multiple urinary estrogens, compared with those used in previous studies that only measured one or two metabolites individually.
The researchers found that increased physical activity was associated with lower levels of parent estrogens. In addition, higher levels of physical activity were associated with lower levels of four specific estrogen metabolites. Dallal cautions, however, that further research on estrogen metabolism will be needed to understand how these metabolites play a role in mediating breast cancer risk.
"By using these new tools to study the relationship between activity and estrogen metabolism, we hope to get closer to uncovering the combination of parent estrogens, metabolites and metabolism pathways that are related to a lower-risk profile of breast cancer," said Dallal.
Source: Newswise
Whole-body-vibration Exercise Proves Ineffective
In postmenopausal women, whole-body vibration exercise fails to boost bone density, shows study.
Advertisement
 HRT Can Reduce Arterial Disease Risk In WomenThe use of hormone replacement therapy can help protect postmenopausal women against the development of peripheral artery disease, a new study suggests. | Advertisement
|
Advertisement
Recommended Readings
Latest Research News
South Korea's total fertility rate, averaging the number of children a woman aged 15-49 has in her lifetime, dropped to 0.81.
Scientists identified mechanisms governing immune cells, selectively removing troublemakers to reshape skin immunity. Benefits those with psoriasis, vitiligo.
By 2050, an anticipated increase from 494 million cases in 2020 to 1.06 billion people with musculoskeletal disabilities is expected.
Experts consulted by GlobalData anticipate a significant overhaul in the Gaucher disease scenario because of forthcoming gene therapies in development.
Within the seven major markets, 12% to 20% of diagnosed prevalent NASH cases present severe liver damage (stage 4 liver fibrosis), denoting cirrhosis.